Skip to main content
. 2021 Jan 26;10(3):e019045. doi: 10.1161/JAHA.120.019045

Table 2.

HR for the Association Between Changes in Pre–Diabetes Mellitus From 2006 to 2008 and the Incidence of CVD and All‐Cause Mortality

Variable Changes in Pre–Diabetes Mellitus
Progression to Diabetes Mellitus Persistent Pre–Diabetes Mellitus Normoglycemia
Myocardial infarction
No. of cases 41 84 55
Incidence rate, per 1000 person‐years 1.97 1.29 0.78
Model 1 Reference 0.73 (0.50–1.07) 0.46 (0.30–0.69)
Model 2 Reference 0.74 (0.51–1.08) 0.45 (0.30–0.69)
Model 3 Reference 0.90 (0.60–1.32) 0.62 (0.40–0.97)
Stroke
No. of cases 132 309 272
Incidence rate, per 1000 person‐years 6.47 4.81 3.93
Model 1 Reference 0.85 (0.69–1.04) 0.71 (0.57–0.88)
Model 2 Reference 0.85 (0.69–1.04) 0.71 (0.58–0.88)
Model 3 Reference 0.91 (0.74–1.12) 0.79 (0.63–0.98)
CVD
No. of cases 166 388 325
Incidence rate, per 1000 person‐years 8.21 6.08 4.71
Model 1 Reference 0.84 (0.70–1.01) 0.67 (0.55–0.81)
Model 2 Reference 0.84 (0.70–1.01) 0.67 (0.55–0.81)
Model 3 Reference 0.93 (0.77–1.12) 0.78 (0.64–0.96)
All‐cause mortality
No. of cases 171 402 368
Incidence rate, per 1000 person‐years 8.40 6.28 5.34
Model 1 Reference 0.86 (0.72–1.04) 0.78 (0.65–0.94)
Model 2 Reference 0.87 (0.72–1.04) 0.78 (0.65–0.94)
Model 3 Reference 0.91 (0.76–1.10) 0.82 (0.68–0.99)

Data are given as HR (95% CI), unless otherwise indicated. Model 1, adjusted for age and sex. Model 2, adjusted for age, sex, income, education, current smoking status, current drinking status, and physical activity. Model 3, adjusted for variables in model 2 plus hypertension, dyslipidemia, fasting plasma glucose, body mass index, estimated glomerular filtration rate, and hs‐CRP (high‐sensitivity C‐reactive protein). CVD indicates cardiovascular disease; and HR, hazard ratio.